MedPath

INPERSOL W DEXTROSE 1.5%

INPERSOL W DEXTROSE 1.5%

Discontinued
DIN Number

00039608

Drug Class

Human

Market Date

Dec 31, 1960

Company
HC

ABBOTT LABORATORIES, LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00039608
AIG Number0500162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationHaemodialysis ,  Intraperitoneal
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (5)

CALCIUM CHLORIDEActive
Strength: .26 MG / ML
Monograph: CALCIUM CHLORIDE
DEXTROSEActive
Strength: 15 MG / ML
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: .15 MG / ML
Monograph: MAGNESIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 5.6 MG / ML
Monograph: SODIUM CHLORIDE
SODIUM LACTATEActive
Strength: 5 MG / ML
Monograph: SODIUM LACTATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.